Proteus Biomedical Receives $25,400,000 New Round

  • Feed Type
  • Date
    12/31/2009
  • Company Name
    Proteus Biomedical
  • Mailing Address
    2600 Bridge Parkway Redwood City, CA 94065
  • Company Description
    Proteus Biomedical was founded in 2001 to apply its state-of-the-art semiconductor technology to the treatment of cardiovascular disease. The Company’s clinical focus is on the management of congestive heart failure (CHF), a debilitating condition resulting from progressive weakening of the heart’s pumping ability.
  • Website
    http://www.proteus.bz
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $25,400,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    The Carlyle Group
  • Venture Investor
    Essex Woodlands Health Ventures
  • Venture Investor
    Undisclosed

Trending on Xconomy